Event snippet :
 

Aalto inside...

OUR PRODUCTS

To play, press and hold the enter key. To stop, release the enter key.

​Aalto Bio Reagents

​

​

​

  • Founded in 1978

​

  • Market leader in the development of proteins and antibodies for new and emerging diseases eg. Chikungunya , Dengue , Zika , Sars , COVID-19 and VEEV virus
     

  • Custom manufacture of new recombinant antigens

​

  • Routine manufacture of bulk antigens and antibodies

​

  • Full raw material menu for chemiluminescence platforms

​

  • Europes largest provider of bulk disease state plasma for controls

​

Aalto's Latest News